ARTIN
DEAD

Serial Number

97184750

Owner

Eglite Erik

Attorney

Erik Eglite

Filing Date

Dec 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ARTIN Trademark

Serial Number: 97184750

ARTIN is a trademark filed by Eglite Erik on December 22, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Eglite Erik (3 trademarks)

875 Mellody Road
Lake Forest, IL 60045

Entity Type: 01

Trademark Details

Filing Date

December 22, 2021

Registration Date

Not Registered

Goods & Services

Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for Respiratory; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives; Cardiovascular pharmaceutical preparations; Cardiovascular pharmaceuticals; Chemical preparations for pharmaceutical or medical purposes, namely, for Respiratory and allergies; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Inhalers filled with Respiratory medication

Providing advertising, marketing and promotional services for the pharmaceutical and medical industry

Dispensing of pharmaceuticals

Masks for inhaling pharmaceutical preparations; Medical apparatus for facilitating the inhalation of pharmaceutical preparations

Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals

Filing History

PETITION TO REVIVE DISMISSED
Feb 15, 2023 PR.D
ASSIGNED TO PETITION STAFF
Feb 13, 2023 APET
PETITION TO REVIVE-RECEIVED
Dec 8, 2022 PETR
TEAS PETITION TO DIRECTOR RECEIVED
Dec 8, 2022 TPDR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 6, 2022 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Oct 5, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 5, 2022 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 23, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 23, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 23, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 28, 2021 NWOS
NEW APPLICATION ENTERED
Dec 25, 2021 NWAP